MeSH term
Frequency | Condition_Probility | *Genetic Techniques | 2 | 3.0 |
Humans | 17 | 0.0 |
In Situ Hybridization, Fluorescence | 4 | 0.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 11 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Up-Regulation | 2 | 0.0 |
Adult | 5 | 0.0 |
Aged | 3 | 0.0 |
Comparative Study | 3 | 0.0 |
Female | 9 | 0.0 |
Male | 7 | 0.0 |
Middle Aged | 6 | 0.0 |
Animals | 4 | 0.0 |
Gene Amplification | 2 | 0.0 |
Mice | 4 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Pregnancy | 2 | 0.0 |
RNA/*genetics | 5 | 15.0 |
*Chromosomes, Human, Pair 3 | 2 | 0.0 |
*Gene Amplification | 3 | 0.0 |
Mutation | 2 | 0.0 |
Adolescent | 3 | 0.0 |
Antibody Formation | 2 | 0.0 |
Apoptosis/immunology | 2 | 2.0 |
Cell Division/immunology | 2 | 0.0 |
Cell Survival/immunology | 2 | 3.0 |
Child | 3 | 0.0 |
Child, Preschool | 2 | 0.0 |
Dyskeratosis Congenita/*genetics/immunology/*pathology | 2 | 100.0 |
Genes, Dominant | 2 | 0.0 |
Homeostasis/immunology | 2 | 20.0 |
Immunity, Cellular | 2 | 0.0 |
Mitosis/immunology | 2 | 33.0 |
Pedigree | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 3 | 0.0 |
T-Lymphocytes/cytology/physiology | 2 | 22.0 |
Telomere/*immunology/*pathology | 2 | 100.0 |
Telomerase/*genetics/metabolism | 2 | 10.0 |
Telomerase/*genetics | 4 | 13.0 |
